DuChemBIO Co.,Ltd. (KOSDAQ:176750)
South Korea · Delayed Price · Currency is KRW 6,350.00
+160.00 (2.58%)
At close: Sep 4, 2026
DuChemBIO Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Net Income | 6,827 | 6,480 | 7,994 | 4,001 |
Depreciation & Amortization | 8,724 | 6,870 | 5,565 | 5,760 |
Loss (Gain) From Sale of Assets | -5.56 | -2.85 | 0.18 | -16.28 |
Asset Writedown & Restructuring Costs | 72.81 | 72.81 | - | 30.7 |
Loss (Gain) From Sale of Investments | -207.24 | -207.24 | -387.82 | -92.13 |
Loss (Gain) on Equity Investments | -259.1 | 24.69 | -1,106 | 69.64 |
Stock-Based Compensation | 65.15 | 58.65 | 31.97 | 236.54 |
Provision & Write-off of Bad Debts | 67.13 | -119.23 | 156.15 | -165.84 |
Other Operating Activities | 705.49 | 589.68 | -2,039 | 929.66 |
Change in Accounts Receivable | -1,012 | -1,865 | -1,834 | -131.89 |
Change in Inventory | -276.38 | 263.61 | -74.64 | -534.11 |
Change in Accounts Payable | -600.95 | -137.55 | -597.38 | 411.37 |
Change in Other Net Operating Assets | -1,457 | -2,088 | -679.24 | -2,057 |
Operating Cash Flow | 12,643 | 9,939 | 7,029 | 8,441 |
Operating Cash Flow Growth | 56.72% | 41.40% | -16.73% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Capital Expenditures | -732.1 | -865.67 | -1,589 | -1,147 |
Sale of Property, Plant & Equipment | 2.71 | - | - | 31 |
Sale (Purchase) of Intangibles | -65.45 | -12.16 | -283.1 | -150 |
Investment in Securities | - | - | 11.06 | - |
Other Investing Activities | -2 | 120 | -204.41 | -132.8 |
Investing Cash Flow | -796.84 | -757.82 | -1,816 | -1,299 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Long-Term Debt Issued | - | 1,000 | - | - |
Long-Term Debt Repaid | - | -5,422 | -7,925 | -7,766 |
Net Debt Issued (Repaid) | -6,126 | -4,422 | -7,925 | -7,766 |
Issuance of Common Stock | 227.61 | - | 11,440 | - |
Other Financing Activities | -0.67 | - | -7.75 | - |
Financing Cash Flow | -5,899 | -4,422 | 3,507 | -7,766 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Foreign Exchange Rate Adjustments | -0.08 | -0.06 | - | -0.19 |
Net Cash Flow | 5,947 | 4,760 | 8,720 | -624.54 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | 11,911 | 9,074 | 5,440 | 7,293 |
Free Cash Flow Growth | 81.45% | 66.81% | -25.41% | - |
Free Cash Flow Margin | 28.70% | 23.52% | 15.28% | 21.02% |
Free Cash Flow Per Share | 418.56 | 319.36 | 202.48 | 272.63 |
Levered Free Cash Flow | 10,844 | 8,061 | 4,629 | - |
Unlevered Free Cash Flow | 11,692 | 8,724 | 5,311 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash Interest Paid | 1,088 | 800.08 | 1,087 | 919.41 |
Cash Income Tax Paid | 394.98 | 259.56 | 144.92 | 90.38 |
Change in Working Capital | -3,346 | -3,827 | -3,185 | -2,312 |